StockData
McKesson Corp logo

McKesson Corp (MCK) stock

MCKNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3027% above fair value
$1069.43+7.27 (+0.68%)

Close on Nov 20, 2026Market cap $124.69BP/E 28.6Yield 0.30%

McKesson gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

McKesson's gross profit for the twelve months ending Jun 30, 2026 was $14.96B, up 11.2% year over year. For fiscal 2026 it was $14.55B, up 9.2% from the year before. Over ten years it grew 2.5% a year on average. The highest annual figure on record is $14.55B in fiscal 2026.

Annual gross profit

PeriodPeriod endValueChange
FY2026Mar 31, 2026$14.55B+9.2%
FY2025Mar 31, 2025$13.32B+3.9%
FY2024Mar 31, 2024$12.83B+3.8%
FY2023Mar 31, 2023$12.36B-5.9%
FY2022Mar 31, 2022$13.13B+8.1%
FY2021Mar 31, 2021$12.15B+1.0%
FY2020Mar 31, 2020$12.02B+2.3%
FY2019Mar 31, 2019$11.75B+5.1%
FY2018Mar 31, 2018$11.18B-0.8%
FY2017Mar 31, 2017$11.27B-1.3%
FY2016Mar 31, 2016$11.42B+0.0%
FY2015Mar 31, 2015$11.41B+36.6%
FY2014Mar 31, 2014$8.35B+21.4%
FY2013Mar 31, 2013$6.88B+7.5%
FY2012Mar 31, 2012$6.40B+7.2%
FY2011Mar 31, 2011$5.97B+5.2%
FY2010Mar 31, 2010$5.68B+5.5%
FY2009Mar 31, 2009$5.38B+7.4%
FY2008Mar 31, 2008$5.01B–

Quarterly gross profit

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026$3.69B+12.4%
Q4 FY2026CQ1 2026Mar 31, 2026$4.04B+11.1%
Q3 FY2026CQ4 2025Dec 31, 2025$3.69B+12.2%
Q2 FY2026CQ3 2025Sep 30, 2025$3.54B+9.1%
Q1 FY2026CQ2 2025Jun 30, 2025$3.28B+4.0%
Q4 FY2025CQ1 2025Mar 31, 2025$3.64B+1.5%
Q3 FY2025CQ4 2024Dec 31, 2024$3.28B+4.2%
Q2 FY2025CQ3 2024Sep 30, 2024$3.25B+5.8%
Q1 FY2025CQ2 2024Jun 30, 2024$3.15B+4.3%
Q4 FY2024CQ1 2024Mar 31, 2024$3.59B+16.9%
Q3 FY2024CQ4 2023Dec 31, 2023$3.15B-0.7%
Q2 FY2024CQ3 2023Sep 30, 2023$3.07B-0.8%
Q1 FY2024CQ2 2023Jun 30, 2023$3.02B-0.0%
Q4 FY2023CQ1 2023Mar 31, 2023$3.07B-7.6%
Q3 FY2023CQ4 2022Dec 31, 2022$3.17B-7.4%
Q2 FY2023CQ3 2022Sep 30, 2022$3.10B-7.7%
Q1 FY2023CQ2 2022Jun 30, 2022$3.02B-0.3%
Q4 FY2022CQ1 2022Mar 31, 2022$3.32B+0.6%
Q3 FY2022CQ4 2021Dec 31, 2021$3.43B+8.8%
Q2 FY2022CQ3 2021Sep 30, 2021$3.35B+11.7%
Q1 FY2022CQ2 2021Jun 30, 2021$3.03B+12.3%
Q4 FY2021CQ1 2021Mar 31, 2021$3.30B-1.2%
Q3 FY2021CQ4 2020Dec 31, 2020$3.15B+3.9%
Q2 FY2021CQ3 2020Sep 30, 2020$3.00B+4.6%
Q1 FY2021CQ2 2020Jun 30, 2020$2.70B-3.1%
Q4 FY2020CQ1 2020Mar 31, 2020$3.34B+4.2%
Q3 FY2020CQ4 2019Dec 31, 2019$3.03B+2.1%
Q2 FY2020CQ3 2019Sep 30, 2019$2.87B+2.2%
Q1 FY2020CQ2 2019Jun 30, 2019$2.79B+0.3%
Q4 FY2019CQ1 2019Mar 31, 2019$3.20B+4.1%
Q3 FY2019CQ4 2018Dec 31, 2018$2.97B+9.4%
Q2 FY2019CQ3 2018Sep 30, 2018$2.80B-1.1%
Q1 FY2019CQ2 2018Jun 30, 2018$2.78B+8.6%
Q4 FY2018CQ1 2018Mar 31, 2018$3.08B+10.0%
Q3 FY2018CQ4 2017Dec 31, 2017$2.72B-3.4%
Q2 FY2018CQ3 2017Sep 30, 2017$2.83B+2.8%
Q1 FY2018CQ2 2017Jun 30, 2017$2.56B–
Q4 FY2017CQ1 2017Mar 31, 2017$2.80B–
Q3 FY2017CQ4 2016Dec 31, 2016$2.81B–
Q2 FY2017CQ3 2016Sep 30, 2016$2.76B–

More McKesson figures

See a number that looks wrong?